Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
105.5 USD | -2.40% | -2.85% | +14.33% |
May. 14 | Stephens Starts Blueprint Medicines With Overweight Rating, $140 Price Target | MT |
May. 06 | Blueprint Medicines Insider Sold Shares Worth $1,050,000, According to a Recent SEC Filing | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.33% | 6.6B | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+47.02% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- BPMC Stock
- News Blueprint Medicines Corporation
- Transcript : Blueprint Medicines Corporation Presents at Goldman Sachs 43rd Annual Global Healthcare Conference, Jun-16-2022 08